US9265740 — Minocycline compounds and methods of use thereof
Formulation · Assigned to Paratek Pharmaceuticals Inc · Expires 2029-03-05 · 3y remaining
What this patent protects
This patent protects methods and compositions for using a tetracycline compound, specifically 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline, to treat bacterial infections.
USPTO Abstract
Methods and compositions for using a tetracycline compound to treat bacterial infections are described. In one embodiment, for example, the invention provides a method of treating a subject for an infection, comprising administering to said subject an effective amount of 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, such that said subject is treated, wherein said infection is selected from the group consisting of MSSA, MRSA, B - streptococci, Viridans Streptococci, Enterococcus , or combinations thereof.
Drugs covered by this patent
- Nuzyra (OMADACYCLINE TOSYLATE) · Paratek Pharms
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1569 |
— | Nuzyra |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.